| Bioactivity | Adafosbuvir (AL-335), a precursor compound of a uridine-based nucleotide analog polymerase (NS5B) inhibitor, has potent antiviral activity against HCV and acts as a potent inhibitor of HCV RNA polymerase[1]. |
| Name | Adafosbuvir |
| CAS | 1613589-09-5 |
| Formula | C22H29FN3O10P |
| Molar Mass | 545.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tetsuo Takehara, et al. JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study. J Gastroenterol. 2020 Jun;55(6):640-652. |
Adafosbuvir
CAS: 1613589-09-5 F: C22H29FN3O10P W: 545.45
Adafosbuvir (AL-335), a precursor compound of a uridine-based nucleotide analog polymerase (NS5B) inhibitor, has potent
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.